NASDAQ:OXFD - Nasdaq -
21.99
+0.01 (+0.05%)
The current stock price of OXFD is 21.99 null. In the past month the price increased by 0.23%. In the past year, price increased by 69.55%.
Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.
Oxford Immunotec
94C INNOVATION DRIVE MILTON PARK
ABINGDON X0 OX14 4RZ
CEO: Peter Wrighton-Smith Ph.D.
Phone: 44-0-12-3544-2780
The current stock price of OXFD is 21.99 null. The price increased by 0.05% in the last trading session.
The exchange symbol of Oxford Immunotec is OXFD and it is listed on the Nasdaq exchange.
OXFD stock is listed on the Nasdaq exchange.
Oxford Immunotec (OXFD) has a market capitalization of 570.90M null. This makes OXFD a Small Cap stock.
Oxford Immunotec (OXFD) has a support level at 21.95 and a resistance level at 22.29. Check the full technical report for a detailed analysis of OXFD support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OXFD does not pay a dividend.
Oxford Immunotec (OXFD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.26).
ChartMill assigns a technical rating of 10 / 10 to OXFD. When comparing the yearly performance of all stocks, OXFD is one of the better performing stocks in the market, outperforming 71.7% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to OXFD. OXFD has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months OXFD reported a non-GAAP Earnings per Share(EPS) of -0.2612. The EPS decreased by -120.9% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -30.51% | ||
ROA | -8.3% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 73% to OXFD. The Buy consensus is the average rating of analysts ratings from 3 analysts.